KVP Capital Advisors »

Savara shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Savara (SVRA) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Savara

Tip: Access up to 7 years of quarterly data

All positions including Savara held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Savara by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 605k 6.03

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Savara

NEA Management Company
Bain Capital Life Sciences Investors
VR Adviser
TCG Crossover Management
Frazier Life Sciences Management
Vanguard Group
Nantahala Capital Management
BlackRock
Deerfield Management Company
Marshall Wace
State Street Corporation
Vestal Point Capital
Rosalind Advisors
Emerald Advisers
Geode Capital Management

View all funds holding Savara